Europe Prenatal Testing Services Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The Europe Prenatal Testing Services Market size is expected to reach US$ 398.9 Million by 2031 from US$ 153.1 Million in 2024. The market is estimated to record a CAGR of 15.0% from 2025 to 2031.

Executive Summary and Europe Prenatal Testing Services Market Analysis:

The Europe prenatal testing services market is classified into Germany, the UK, France, Spain, Italy, and the Rest of Europe. In Europe, NIPT implementation is heterogeneous. Around 14 countries formally integrate NIPT into their national prenatal screening programs. Nevertheless, the methods of implementation vary. NIPT is available to everyone in Belgium and the Netherlands, whereas in other European countries, it is reserved for high-risk individuals after a first-trimester biochemical test. Ethics and access have been two primary topics of discussion in Europe. In the Netherlands, professionals are concerned about providing truly informed consent and ensuring fair access, given the differences in socioeconomic levels. A collaborative research project (England, France, and Germany) is investigating how genome testing in antenatal care influences issues regarding risk thresholds, professional regulation, and changes in the perception of disability in policy and practice.

Europe Prenatal Testing Services Market: Strategic Insights

Europe Prenatal Testing Services Market Segmentation Analysis:

• By Diagnostic Type, the Europe Prenatal Testing Services Market is segmented into Non Invasive and Invasive. The Non Invasive segment dominated the market in 2024.
• By Disease, the Europe Prenatal Testing Services Market is segmented into Aneuploidy, Microdeletions, Structural Chromosomal Abnormalities, and Others. The Aneuploidy segment dominated the market in 2024.
• By End User, the Europe Prenatal Testing Services Market is segmented into Hospitals, Diagnostic Laboratories, Specialty Clinics, and Other End Users. The Hospitals segment dominated the market in 2024.

Europe Prenatal Testing Services Market Players Density: Understanding Its Impact on Business Dynamics

The Europe Prenatal Testing Services Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Europe Prenatal Testing Services Market Outlook

According to the World Health Organization (WHO), congenital anomalies affect nearly 6% of the worldwide population and continue to be a leading cause of infant mortality and morbidity. In 2021, the number of children with congenital disabilities was roughly 7.2 million, which is a significant increase compared to past years. The most common structural anomalies are congenital heart defects and neural tube defects, whereas chromosomal disorders, including Down syndrome, dominate among the genetic ones.

Genetics plays a vital role in these diseases. Data from the National Congenital Anomaly and Rare Disease Registration Service in England indicates that in 2021, genetic disorders were responsible for 69.2 per 10,000 births, which is the first time this number has been higher than that of congenital heart disease, a sign of more sensitive and wider detection. A recent worldwide meta-study published in Springer Nature, has highlighted that the birth prevalence of congenital anomalies (i.e., anorectal malformations, diaphragmatic hernia) ranges from 0.86 to 3.11 per 10,000 births, underscoring the fact that these infrequent but impactful defects result in high morbidity figures.

The growing number of cases of congenital and genetic disorders is increasing the necessity of prenatal screening. An increasing number of families and clinicians are becoming aware of the risks and consequences associated with these anomalies, and hence demand early and precise diagnosis. NIPT is the safest and most reliable method for detecting chromosomal abnormalities during pregnancy. It can be extended to cover a wide range of genetic conditions, thereby reducing the need for invasive procedures. At the same time, new developments in ultrasound, bioinformatics, and genetic counseling lead to an increased level of assurance in prenatal screening. Thus, the upsurge in the prevalence of congenital and genetic disorders propels the demand for prenatal testing services that parents and healthcare providers have turned to as a portfolio of proactive detection, risk management, and informed decision-making tools.

Europe Prenatal Testing Services Market Country Insights

By country, the Europe Prenatal Testing Services Market is segmented into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. The Rest of Europe held the largest share in 2024.

Belgium, Russia, Luxembourg, Ukraine, Croatia and Cyprus, Romania, Slovakia, and Slovenia are among the key nations contributing to the prenatal testing services market in the Rest of Europe. The countries have a varied NIPT adoption rate. The differences are dependent on the local healthcare systems, policy decisions, and ethical frameworks of each country. According to recent comparative studies, European countries have introduced a contingent screening model, whereby NIPT is provided only after a first-trimester risk assessment based on combined biochemical and ultrasound markers. Countries in Central and Eastern Europe consider NIPT a service that is typically performed privately. A few of them have already established reimbursement schemes, while others are still in the early stages of this process.

Ethical issues such as obtaining informed consent, the possibility of routine usage, and the disclosure of incidental or rare chromosomal abnormalities are being discussed publicly. Some countries are considering policy changes, such as standardizing the criteria for screening eligibility, expanding the number of labs, and enhancing the quality of counseling, to address these issues. Although the pan-EU labs offer extended panels (rare aneuploidies, microdeletions) more frequently, public systems are still underfunded for such comprehensive tests.

Europe Prenatal Testing Services Market Company Profiles

Some of the key players operating in the market include F. Hoffmann-La Roche Ltd, Illumina Inc, Quest Diagnostics Inc, Exact Sciences Corp, Eurofins Scientific SE, Myriad Genetics Inc, Revvity Inc, Laboratory Corp of America Holdings, MedGenome Inc, and Fulgent Genetics, Inc.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Europe Prenatal Testing Services Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise